Subramanyam Maddala
In his new role, Maddala will take charge of the firm’s Indian API manufacturing, including operations at its facilities in Hyderabad and Aurangabad.
He comes to AMRI from Shasun Pharmaceuticals, where he served as vice president of contract research and manufacturing services new generics.
Dr. Steven Hagen, vice president of pharmaceutical development and manufacturing at AMRI said: “We are pleased to welcome Mr. Maddala to the AMRI leadership team and believe he is the right person to take AMRI’s chemical manufacturing business in India to the next level, including the capability to eventually manufacture multiple products in India to U.S. FDA standards.”